FADD and ovarian carcinoma: Further studies have revealed that SAL overcomes multidrug resistance in cisplatin-resistant ovarian cancer cells (A2780cis) by enhancing apoptosis through the upregulation of DR5 (death receptor-5), caspase-8, and FADD (Fas-associated protein with death domain) [8].